By- Legalxpo Interns
The Supreme Court of India on Monday lifted the ban on sale of painkiller Saridon and two other drugs. The recent ruling came in the wake of 13 september order by Ministry of Health that had banned manufacture for sale or distribution of 328 Fixed Dose Combination (FDC) drugs . Banned medicines included brands like Diramal Healthcare’s Saridon, Alkem Laboratories and Taxim AZ.
The Public Health Experts and the Doctors in India and abroad had warned against increasing use of antibiotic combinations. The excess use of it may lead to the contribution to antibiotic resistance.
The bench comprised of Justices RF Nariman and Indu Malhotra issued the notice to centre on the plea filled by some drug makers and pharma associations. The Bench asked for reply on the matter from center within a week. In India the market share on combination vs single drug is bigger than anywhere in the world. The expert panel had reported to center that the ingredients contained in 328 FDC may involve risk to human beings. Further the report also said that there is no need to expose the patients to that many ingredients when one will do the work.
Hence the Ministry issued a notice which stated ” Hence in larger public interest it is necessary to prohibit the manufacture, sale or distribution of this FDC and any kind of regulation or restriction to allow for any use on patients is not justifiable”.
We are sorry that this post was not useful for you!
Let us improve this post!
Tell us how we can improve this post?